AssetMark’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
Other funds holding AGIO
AssetMark's AGIO Position: Q3 2026 in Review
AssetMark increased its Agios Pharmaceuticals (AGIO) stake by 20% in Q3 2026, buying an estimated $9.16K and bringing the position to 1,579 shares worth $52.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1868.
AssetMark first reported a position in AGIO in Q1 2024 and has held it in 11 quarters since. 181 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.
- AssetMark held 1,579 shares of Agios Pharmaceuticals worth $52.5K as of Q3 2026.
- AssetMark bought 262 Agios Pharmaceuticals shares in Q3 2026, an estimated $9.16K.
- Agios Pharmaceuticals made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #1868 holding.
- AssetMark first reported a position in Agios Pharmaceuticals in Q1 2024 and has held it in 11 quarters since.
- 181 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.